المؤلفون: Sylvia Illouz, Michael Pablo, Xinyue Chen, Thomas F. Rogers, Arjun Kumar, Leo Holguin, Robert Rodick, Davey M. Smith, Nathan Beutler, Gustavo Vasen, Donna Rahgoshay, Melanie Ott, John C. Burnett, Pei-Yi Chen, Leor S. Weinberger, Elizabeth Tanner, Blaise Ndjamen, Sonali Chaturvedi

المصدر: Cell
Cell, vol 184, iss 25

مصطلحات موضوعية: Male, Mutant, coronavirus, medicine.disease_cause, Virus Replication, Medical and Health Sciences, therapeutic interfering particles, Drug Delivery Systems, Virus-like particle, Conditioned, Chlorocebus aethiops, Lung, Coronavirus, variants, intranasal, Biological Sciences, lipid nanoparticle, Infectious Diseases, Defective interfering particle, Pneumonia & Influenza, Defective Interfering Viruses, Infection, Biology, Antiviral Agents, General Biochemistry, Genetics and Molecular Biology, Virus, Article, Cell Line, virus-like particle, defective interfering particle, (DIP), basic reproductive ratio, (R0), Vaccine Related, defective interfering particles, Biodefense, evolution, medicine, Animals, Humans, Vero Cells, Mesocricetus, SARS-CoV-2, Prevention, RNA, COVID-19, Epithelial Cells, Pneumonia, Virology, lipid nanoparticle, (LNP), Culture Media, COVID-19 Drug Treatment, Emerging Infectious Diseases, Good Health and Well Being, Viral replication, Culture Media, Conditioned, Nanoparticles, Nasal administration, therapeutic interfering particle, (TIP), Developmental Biology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87e5c6d3a79086e54ec8f5adbed5e35
http://europepmc.org/articles/PMC8577993